Annual Report Details 2025 Financial Decline, Subsidiary Dilution, and Persistent Geopolitical Risks

check_boxKey Events

• 2025 Financial Performance Decline

  Net income attributable to ACM Research, Inc. decreased to $94.078 million in 2025 from $103.627 million in 2024. Basic EPS fell to $1.47 from $1.67, and diluted EPS to $1.37 from $1.53. Operating activities resulted in a net cash outflow of $10.325 million in 2025, a significant reversal from the $152.450 million inflow in 2024, indicating operational challenges despite a 15.2% revenue increase to $901.309 million.

• Significant Subsidiary Capital Raise and Ownership Dilution

  In September 2025, ACM Research's Shanghai operating subsidiary completed a private offering, selling 38,601,326 ordinary shares for approximately $623.0 million in net proceeds. This transaction reduced ACM Research's ownership interest in ACM Shanghai from 81.5% to 74.6%.

• Persistent Geopolitical and Regulatory Risks Detailed

  The report extensively details ongoing risks from U.S.-China trade tensions, including the December 2, 2024, addition of ACM Shanghai and ACM Korea to the BIS Entity List, which restricts access to U.S. export-controlled hardware, software, and technologies. New U.S. Outbound Investment Security Program (OISP) regulations and the COINS Act are also discussed, potentially limiting cross-border investment opportunities, though the COINS Act is expected to reverse OISP application for ACM Research in 2026 or 2027.

• Insider 10b5-1 Trading Plans Adopted

  Three key individuals – Director Charles Pappis (10,000 shares), ACM Shanghai CFO Lisa Feng (30,000 shares), and Director Tracy Liu (60,000 shares) – adopted Rule 10b5-1 trading arrangements in late 2025 to sell Class A Common Stock starting in March 2026. These are pre-planned sales, but represent a notable aggregate volume of shares.

auto_awesomeAnalysis

This annual report provides a comprehensive overview of ACM Research's 2025 fiscal year, revealing a decline in net income and a shift to negative operating cash flow, despite overall revenue growth. A significant event was the private offering by its Shanghai subsidiary, which raised substantial capital but diluted ACM Research's ownership. The filing also reiterates and elaborates on the critical geopolitical risks, including the U.S. BIS Entity List designation for its key subsidiaries and the evolving U.S. outbound investment regulations, which pose ongoing challenges to its China-centric operations. The combination of declining profitability, negative operating cash flow, and high-impact regulatory risks makes this a very important filing for investors to understand the company's operational health and future outlook.